Now showing items 11-20 of 21
Recommended Guidelines for the Conduct and Evaluation of Prognostic Studies in Veterinary Oncology
(Sage Publications Inc, 2011-01-01)
There is an increasing need for more accurate prognostic and predictive markers in veterinary oncology because of an increasing number of treatment options, the increased financial costs associated with treatment, and the ...
NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-lambda B signaling
(Impact Journals Llc, 2016-05-31)
Therapeutic Innovations: Tyrosine Kinase Inhibitors in Cancer
Conventional cytotoxic chemotherapy involving DNA-interacting agents and indiscriminate cell death is no longer the future of cancer management. While chemotherapy is not likely to completely disappear from the armamentarium; ...
Combined Gemcitabine and Carboplatin Therapy for Carcinomas in Dogs
(Wiley-Blackwell Publishing, Inc, 2009-01-01)
Background: Response and adverse reactions to combined gemcitabine (GEM) and carboplatin (CARBO) therapy in dogs with carcinomas are not documented. Hypothesis: GEM and CARBO are safe for the treatment of dogs with ...
Geographical differences in survival of dogs with non-Hodgkin lymphoma treated with a CHOP based chemotherapy protocol
(Blackwell Publishing Ltd, 2017-04-17)
Background: In humans geographical differences in the incidence and presentation of various cancers have been reported. However, much of this information has not been collected in veterinary oncology. Aims: The purpose ...
Safety of concurrent administration of dexrazoxane and doxorubicin in the canine cancer patient
(Wiley-Blackwell Publishing, Inc, 2010-12-01)
Doxorubicinmay cause a rare but serious cardiotoxicity. Dexrazoxane is a cardioprotectant drug used to reduce the risk of cardiotoxicity in human patients. In this study, 25 tumour-bearing dogs were treated with concurrent ...
Tolerability of Gemcitabine and Carboplatin Doublet Therapy in Cats with Carcinomas
(Wiley-Blackwell Publishing, Inc, 2009-05-01)
Background: This study was performed to determine the toxicity of gemcitabine-carboplatin doublet therapy in cats with carcinomas. Hypothesis: Gemcitabine and carboplatin are safe in tumor-bearing cats. Animals: ...
Invited Review-Neuroimaging Response Assessment Criteria for Brain Tumors in Veterinary Patients
Treatment with DAV for Advanced-Stage Hemangiosarcoma in Dogs
(Amer Animal Hospital Assoc, 2011-05-01)
Hemangiosarcoma (HSA) is an aggressive disease that is fairly common in the dog. The authors evaluated a doxorubicin, dacarbazine, and vincristine (DAV) combination protocol in dogs with nonresectable stage II and stage ...
Use of an image-guided robotic radiosurgery system for the treatment of canine nonlymphomatous nasal tumors
An image-guided robotic stereotactic radiosurgery (SRS) system can be used to deliver curative-intent radiation in either single fraction or hypofractionated doses. Medical records for 19 dogs with nonlymphomatous nasal ...